Population-Level Decision Curve Analysis May Mislead the Evaluation of Prediction Model Usefulness under Subgroup Utility Heterogeneity

📅 2026-09-28
📈 Citations: 0
✨ Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the risk that subgroup utility heterogeneity may lead decision curve analysis (DCA) at the population level to misjudge the true clinical utility of predictive models. Through rigorous mathematical derivation, this work constructs a discordance region model to quantify, for the first time, the interference boundaries imposed by such heterogeneity on DCA conclusions, validated via subgroup-specific net benefit analyses and real-world case studies. The findings reveal that when incremental net benefits across subgroups exhibit opposing signs, population-level net benefit may obscure true utility. Accordingly, an early-warning mechanism based on sign-discordant ΔNB and a robustness evaluation framework are proposed. This research demonstrates that employing population net benefit as a proxy for utility necessitates the assumption of subgroup homogeneity, thereby providing practical tools for identifying and mitigating failures in DCA-based conclusions.
📝 Abstract
Background Decision curve analysis (DCA) evaluates prediction model usefulness using net benefit (NB). Population-level NB is often interpreted as a proxy for population-level expected utility, but this assumes comparability of utility across subgroups. We aimed to characterize when subgroup utility heterogeneity may invalidate population-level DCA conclusions. Methods We compared prediction-driven treatment with default strategies in populations containing subgroups with different utility values. We derived an inconsistency region: combinations of subgroup-specific ΔNB values for which population-level NB and utility favor different strategies. We also developed a practical robustness framework. Results Opposite signs of subgroup-specific ΔNB provide a warning signal for possible inconsistency. The inconsistency region is larger when subgroup sizes are more similar and subgroup-specific \(a-c\) values are more different, where \(a-c\) is the incremental utility of a true positive relative to a false negative. When \(a-c\) differs across subgroups, population-level NB combines quantities on different implicit utility scales and may conflict with population utility. A real-world case study illustrates the problem. Conclusions Using population-level NB as a proxy for population utility implicitly assumes homogeneous \(a-c\) across subgroups. Subgroup DCA and our framework can identify and assess when utility heterogeneity may invalidate population-level conclusions.
Problem

Research questions and friction points this paper is trying to address.

Decision Curve Analysis
Net Benefit
Subgroup Utility Heterogeneity
Prediction Model Evaluation
Expected Utility
Innovation

Methods, ideas, or system contributions that make the work stand out.

Decision Curve Analysis
Subgroup Utility Heterogeneity
Net Benefit
Inconsistency Region
Robustness Framework
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
No related jobs found.
Junfeng Wang
Junfeng Wang
Baidu Inc
SearchLarge Language Model
K
Kim Zhipei Wang
Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
Ben Van Calster
Ben Van Calster
Professor of Medical Statistics, KU Leuven
Prediction modelingbiostatistics
Nan van Geloven
Nan van Geloven
Assistant professor biostatistics, Leiden University medical center
biostatistics
E
Ewout Steyerberg
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
L
Laure Wynants
Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands; Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Leuven Unit for Health Technology Assessment Research (LUHTAR), KU Leuven, Leuven, Belgium